Surgery Partners (SGRY) Set to Announce Quarterly Earnings on Tuesday

Surgery Partners (NASDAQ:SGRY) is set to release its earnings data before the market opens on Tuesday, May 7th. Analysts expect Surgery Partners to post earnings of $0.07 per share for the quarter. Persons that wish to register for the company’s earnings conference call can do so using this link.

Surgery Partners (NASDAQ:SGRY) last released its quarterly earnings results on Monday, February 26th. The company reported $0.44 EPS for the quarter, beating analysts’ consensus estimates of $0.37 by $0.07. The business had revenue of $735.40 million during the quarter, compared to analyst estimates of $741.93 million. Surgery Partners had a positive return on equity of 3.65% and a negative net margin of 0.43%. Surgery Partners’s quarterly revenue was up 4.0% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.22 EPS. On average, analysts expect Surgery Partners to post $1 EPS for the current fiscal year and $1 EPS for the next fiscal year.

Surgery Partners Trading Down 1.9 %

NASDAQ SGRY opened at $24.53 on Friday. The firm has a market capitalization of $3.12 billion, a P/E ratio of -245.30, a PEG ratio of 2.29 and a beta of 2.75. The business has a fifty day simple moving average of $27.63 and a 200 day simple moving average of $29.76. Surgery Partners has a 12 month low of $22.05 and a 12 month high of $45.79. The company has a current ratio of 1.71, a quick ratio of 1.57 and a debt-to-equity ratio of 0.89.

Analyst Upgrades and Downgrades

A number of research firms recently commented on SGRY. Barclays began coverage on Surgery Partners in a research report on Wednesday, March 6th. They issued an “equal weight” rating and a $35.00 price target for the company. Royal Bank of Canada reaffirmed an “outperform” rating and set a $49.00 target price on shares of Surgery Partners in a research report on Thursday, February 29th. Benchmark reaffirmed a “buy” rating and set a $50.00 target price on shares of Surgery Partners in a research report on Wednesday. StockNews.com raised Surgery Partners from a “sell” rating to a “hold” rating in a research report on Thursday, March 21st. Finally, Citigroup decreased their target price on Surgery Partners from $43.00 to $42.00 and set a “buy” rating for the company in a research report on Tuesday, February 27th. Two analysts have rated the stock with a hold rating and seven have given a buy rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and a consensus target price of $43.63.

Insider Buying and Selling

In other Surgery Partners news, CFO David T. Doherty sold 1,020 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $34.93, for a total value of $35,628.60. Following the completion of the transaction, the chief financial officer now owns 74,209 shares in the company, valued at approximately $2,592,120.37. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. In other Surgery Partners news, CFO David T. Doherty sold 1,020 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $34.93, for a total value of $35,628.60. Following the completion of the transaction, the chief financial officer now owns 74,209 shares in the company, valued at approximately $2,592,120.37. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Jason Eric Evans sold 5,780 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $35.08, for a total value of $202,762.40. Following the completion of the transaction, the chief executive officer now owns 419,118 shares of the company’s stock, valued at approximately $14,702,659.44. The disclosure for this sale can be found here. In the last 90 days, insiders sold 14,831 shares of company stock valued at $482,609. 2.60% of the stock is owned by insiders.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.